Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Pennsylvania State Senator Doug Mastriano (R-Franklin/Adams) announced he is introducing a bill that would ensure the state’s food remains free from unauthorized vaccines or ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

Acquisition to strengthen key pillar of BioNTech's oncology strategy aimed at establishing BNT327 as a pan-tumor technology platform for the treatment of advanced cancersWith the closing of the transa ...

A US-based pharmaceutical company known for its revolutionary mRNA technology, has completed construction of its Moderna Innovation and Technology Centre (MITC) at Harwell in Oxfordshire.